Pharmacogenomics is the study of the role of the genome in drug response. Its name reflects its combining of pharmacology and genomics. Pharmacogenomics analyzes how the genetic makeup of an individual affects his/her response to drugs.According to this study, over the next five years the Pharmacogenomics (PGx) market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global revenue market share of key companies in Pharmacogenomics (PGx) business, shared in Chapter 3.

This report presents a comprehensive overview, market shares and growth opportunities of Pharmacogenomics (PGx) market by product type, application, key companies and key regions.This study considers the Pharmacogenomics (PGx) value generated from the sales of the following segments:

Download FREE Sample of this Report @

Segmentation by product type: breakdown data from 2014 to 2019 in Section 2.3; and forecast to 2024 in section 10.7.

  • Polymerase Chain Reaction (PCR)
  • Microarray
  • Other

Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 10.8.

  • Cardiovascular Diseases (CVD)
  • Central Nervous System (CNS)
  • Cancer/Oncology
  • Infectious Diseases
  • Other

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

  • Americas
  • United States
  • Canada
  • Mexico
  • Brazil
  • APAC
  • China
  • Japan
  • Korea
  • Southeast Asia
  • India
  • Australia
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Russia
  • Spain
  • Middle East & Africa
  • Egypt
  • South Africa
  • Israel
  • Turkey
  • GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.

  • Abbott Laboratories
  • Affymetrix, Inc.
  • Assurex Health, Inc
  • Astrazeneca
  • GeneDX
  • Illumina, Inc.
  • Laboratory Corporation of America Holdings
  • Myriad Genetics, Inc.
  • Pathway Genomics
  • Pfizer, Inc
  • Qiagen, Inc.
  • Rocheg
  • Teva Pharmaceutical Industries Ltd.
  • Thermo Fisher Scientific
  • Transgenomic, Inc.

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

  • To study and analyze the global Pharmacogenomics (PGx) market size by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
  • To understand the structure of Pharmacogenomics (PGx) market by identifying its various subsegments.
  • Focuses on the key global Pharmacogenomics (PGx) players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
  • To analyze the Pharmacogenomics (PGx) with respect to individual growth trends, future prospects, and their contribution to the total market.
  • To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
  • To project the size of Pharmacogenomics (PGx) submarkets, with respect to key regions (along with their respective key countries).
  • To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
  • To strategically profile the key players and comprehensively analyze their growth strategies.

Get the Complete Report & TOC @

Table of content

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Pharmacogenomics (PGx) Market Size 2014–2024
2.1.2 Pharmacogenomics (PGx) Market Size CAGR by Region
2.2 Pharmacogenomics (PGx) Segment by Type

Key Que Answered in this report:

  1. What will the Global Pharmacogenomics Market?
  2. What are the key factors Pharmacogenomics Market?
  3. What are the key market trends in the Pharmacogenomics Market?
  4. improve pasting the growth of this Pharmacogenomics market?
  5. What are the market opportunities and threats faced by the Pharmacogenomics Market?
  6. What are the key outcomes of the five forces analysis of the Pharmacogenomics Market?

What is our report offers:

Strategic suggestions and proposals for the beginners to understand
Assessments of the market share from different countries and regions were conducted
Top key market players, market share analysis included.
The market observations such as constraints, drivers, threats, opportunities, investment opportunities, challenges, and recommendations are added.
The competitive landscaping mappings of the ongoing trends are discussed.
Based on the market estimations, the strategic recommendations are made in the business segments

276 5th Avenue, New York, NY 10001, United States
International: (+1) 646 781 7170 / +91 8087042414

Follow Us On LinkedIn:-


Please enter your comment!
Please enter your name here